WallStreetZenWallStreetZen

NASDAQ: LFMD
Lifemd Inc Stock Forecast, Predictions & Price Target

Analyst price target for LFMD

Based on 5 analysts offering 12 month price targets for Lifemd Inc.
Min Forecast
$11.00+8.06%
Avg Forecast
$12.60+23.77%
Max Forecast
$15.00+47.35%

Should I buy or sell LFMD stock?

Based on 5 analysts offering ratings for Lifemd Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LFMD stock forecasts and price targets.

LFMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-12

1 of 1

Forecast return on equity

Is LFMD forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is LFMD forecast to generate an efficient return on assets?

LFMD revenue forecast

What is LFMD's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$203.2M+33.2%
Avg 2 year Forecast
$258.4M+69.38%
LFMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LFMD revenue growth forecast

How is LFMD forecast to perform vs Health Information Services companies and vs the US market?
Company
33.2%
Industry
13.39%
Market
13.87%
LFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LFMD vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
LFMD$10.18$12.60+23.77%Strong Buy
HCAT$7.44$11.89+59.80%Strong Buy
SOPH$5.26$8.00+52.09%Strong Buy
SPOK$15.88N/AN/A
SHCR$0.84N/AN/A

Lifemd Stock Forecast FAQ

Is Lifemd Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: LFMD) stock is to Strong Buy LFMD stock.

Out of 5 analysts, 3 (60%) are recommending LFMD as a Strong Buy, 2 (40%) are recommending LFMD as a Buy, 0 (0%) are recommending LFMD as a Hold, 0 (0%) are recommending LFMD as a Sell, and 0 (0%) are recommending LFMD as a Strong Sell.

If you're new to stock investing, here's how to buy Lifemd stock.

What is LFMD's revenue growth forecast for 2024-2025?

(NASDAQ: LFMD) Lifemd's forecast annual revenue growth rate of 33.2% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.87%.

Lifemd's revenue in 2024 is $152,547,006.On average, 2 Wall Street analysts forecast LFMD's revenue for 2024 to be $8,201,775,260, with the lowest LFMD revenue forecast at $8,148,693,908, and the highest LFMD revenue forecast at $8,254,856,612.

In 2025, LFMD is forecast to generate $10,430,182,884 in revenue, with the lowest revenue forecast at $10,430,182,884 and the highest revenue forecast at $10,430,182,884.

What is LFMD's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: LFMD) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 6.3%.

What is LFMD's Price Target?

According to 5 Wall Street analysts that have issued a 1 year LFMD price target, the average LFMD price target is $12.60, with the highest LFMD stock price forecast at $15.00 and the lowest LFMD stock price forecast at $11.00.

On average, Wall Street analysts predict that Lifemd's share price could reach $12.60 by Mar 15, 2025. The average Lifemd stock price prediction forecasts a potential upside of 23.77% from the current LFMD share price of $10.18.

What is LFMD's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: LFMD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.